EV/EBITDA:
262.99+9.45(+3.73%)Summary
- As of today, PTGX EV/EBITDA is 262.99, with a rise of +9.45 (+3.73%) during the most recent trading session on December 12, 2025.
- Over the past year, PTGX EV/EBITDA has increased by +250.19 (+1954.61%).
- PTGX EV/EBITDA is now at all-time high.
Performance
PTGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PTGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +3.7% | +3.7% | +3.4% |
| 1M1 Month | +13.8% | +13.8% | +12.4% |
| 3M3 Months | +127.5% | +73.9% | +62.0% |
| 6M6 Months | +170.6% | +84.3% | +69.3% |
| YTDYTD | +3351.3% | +177.0% | +147.0% |
| 1Y1 Year | +1954.6% | +176.9% | +136.1% |
| 5Y5 Years | +2555.6% | +748.9% | +343.1% |
PTGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 262.99 | at high | 226.09 | +16.3% |
| 3M | 3-Month | 262.99 | at high | 114.49 | +129.7% |
| 6M | 6-Month | 262.99 | at high | 91.07 | +188.8% |
| 1Y | 1-Year | 262.99 | at high | 6.83 | +3750.5% |
| 3Y | 3-Year | 262.99 | at high | -16.97 | +1649.7% |
| 5Y | 5-Year | 262.99 | at high | -27.68 | +1050.1% |
| All-Time | All-Time | 262.99 | at high | -27.68 | +1050.1% |
PTGX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 262.99(+3351.3%) |
| 2024 | 7.62(+170.0%) |
| 2023 | -10.88(-357.1%) |
| 2022 | -2.38(+77.7%) |
| 2021 | -10.69(-13.0%) |
| Date | Value |
|---|---|
| 2020 | -9.46(-836.6%) |
| 2019 | -1.01(-46.4%) |
| 2018 | -0.69(+91.4%) |
| 2017 | -8.06(+10.1%) |
| 2016 | -8.97 |
FAQ
- What is Protagonist Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?
- What is PTGX EV/EBITDA year-to-date change?
- What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Protagonist Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of PTGX is 262.99
What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high EV/EBITDA is 262.99
What is PTGX EV/EBITDA year-to-date change?
Protagonist Therapeutics, Inc. EV/EBITDA has changed by +255.37 (+3351.31%) since the beginning of the year
What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, PTGX EV/EBITDA has changed by +250.19 (+1954.61%)